Myeloma Canada’s Board of Scientific Advisors is comprised of recognized Canadian leaders in the field of myeloma. The goals of the Board are to provide valuable counsel and support Myeloma Canada's mission to promote awareness, education and research for the Canadian myeloma community.
Dr. Andrew R. Belch (Chairman) Department of Oncology University of Alberta Cross Cancer Institute Edmonton, AB Dr. Nizar Bahlis University of Calgary Division of Hematology and Bone Marrow Transplant Calgary, AB Dr. Christine Chen Princess Margaret Hospital University of Toronto Toronto, ON Dr. Linda Pilarski* Department of Oncology University of Alberta Cross Cancer Institute Edmonton, AB Dr. Donna E. Reece* Princess Margaret Hospital University of Toronto Toronto, ON Dr. Tony Reiman Saint John Regional Hospital Saint John, NB Dr. Jean Roy Hôpital Maisonneuve-Rosemont Université de Montréal Montréal, QC Dr. Chaim Shustik* Royal Victoria Hospital McGill University Montréal, QC Dr. Kevin Song BC Cancer Research Centre Vancouver General Hospital Vancouver, BC Dr. Darrell White Dalhousie University Nova Scotia Cancer Centre Queen Elizabeth II Health Services Centre Halifax, NS
Dr. Suzanne Trudel Princess Margaret Hospital University of Toronto Toronto, ON Dr. Richard LeBlanc Hôpital Maisonneuve-Rosemont Université de Montréal Montréal, QC
* Drs. Pilarski, Reece et Shutsik are also membres of the scientific advisory board of the IMF.
Get the PDF version of the myeloma handbook by clicking here...
Myeloma Canada is affiliated with the International Myeloma Foundation, the world's oldest and largest myeloma organization
Myeloma Canada gratefully acknowledges the generous unrestricted educational grants from our website sponsors:
Ortho Biotech Celgene The Binding Site Amgen
